Literature DB >> 2066790

Insular carcinoma: a distinct thyroid carcinoma with associated iodine-131 localization.

E P Justin1, J E Seabold, R A Robinson, W P Walker, N J Gurll, D R Hawes.   

Abstract

Insular carcinoma, once considered a poorly-differentiated thyroid cancer, has been reclassified as a distinct thyroid neoplasm. Since this neoplasm is composed of follicular epithelial cells, it may concentrate radioiodide (131I) making postoperative 131I imaging for detection of metastases and radiotherapy possible. A 20-yr review of 35 cases diagnosed as anaplastic or undifferentiated thyroid carcinoma at this medical center revealed five patients with insular carcinoma. Four patients showed postoperative 131I localization and received therapeutic doses of 131I. Three of the four showed extrathyroidal 131I localization in neoplastic lesions. In one patient, the resolution of metastatic lesions by magnetic resonance and 131I imaging suggests that 131I may have an important therapeutic role in this aggressive neoplasm.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2066790

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  11 in total

Review 1.  Unusual types of thyroid cancer.

Authors:  K B Ain
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

Review 2.  An evidence-based review of poorly differentiated thyroid cancer.

Authors:  Enoch M Sanders; Virginia A LiVolsi; James Brierley; Jennifer Shin; Gregory W Randolph
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

3.  Insular carcinomas of the thyroid exhibit poor prognosis and long-term survival in comparison to follicular and papillary T4 carcinomas.

Authors:  Ayman Agha; Gabriel Glockzin; Matthias Woenckhaus; Wolfgang Dietmaier; Igors Iesalnieks; Hans J Schlitt
Journal:  Langenbecks Arch Surg       Date:  2007-01-10       Impact factor: 3.445

4.  Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21.

Authors:  K Y Lam; C Y Lo; K W Chan; K Y Wan
Journal:  Ann Surg       Date:  2000-03       Impact factor: 12.969

5.  Insular thyroid carcinoma in a young Moroccan man: Case report and review of the literature.

Authors:  Wahiba Abdellaoui; Imane Assarrar; Salma Benyakhlef; Abir Tahri; Najoua Messaoudi; Anass Haloui; Siham Rouf; Amal Bennani; Hanane Latrech
Journal:  Ann Med Surg (Lond)       Date:  2022-04-06

6.  Re-evaluation of histopathological factors affecting prognosis of differentiated thyroid carcinoma in an iodine-sufficient country.

Authors:  Iwao Sugitani; Kazuhisa Toda; Noriko Yamamoto; Atsuhiko Sakamoto; Yoshihide Fujimoto
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

7.  Poorly differentiated thyroid carcinoma: 5 years after the 2004 WHO classification of endocrine tumours.

Authors:  Marco Volante; Mauro Papotti
Journal:  Endocr Pathol       Date:  2010-03       Impact factor: 3.943

8.  Insular carcinoma: infrequent subtype of thyroid cancer with aggressive clinical course.

Authors:  Tzu-Chieh Chao; Jen-Der Lin; Miin-Fu Chen
Journal:  World J Surg       Date:  2004-03-04       Impact factor: 3.352

9.  Insular thyroid carcinoma in a Filipino woman.

Authors:  Mark Anthony S Sandoval; Elizabeth Paz-Pacheco
Journal:  BMJ Case Rep       Date:  2010-11-18

10.  Neoadjuvant chemotherapy in 13 patients with locally advanced poorly differentiated thyroid carcinoma based on Turin proposal - a single institution experience.

Authors:  Nikola Besic; Marta Dremelj; Andreja Schwartzbartl-Pevec; Barbara Gazic
Journal:  Radiol Oncol       Date:  2015-08-21       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.